GlassScriptPhysician profile
Sami Pervaiz
NPI 1528592631
$4,771.73
in general payments reported to CMS, 2019-2025
21 companies · $2,461 in 2025
The $2,461 reported for 2025 was more than what 79% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $42.10 · 2021: $339 · 2023: $565 · 2024: $1,365 · 2025: $2,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,291 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,290.79 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,040.68 | 2023-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $868.93 | 2023-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Phathom Pharmaceuticals, INC. | $367.06 | 2024-2025 | Voquezna |
| Janssen Pharmaceuticals, INC | $249.73 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $207.85 | 2023-2025 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $159.43 | 2020-2025 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Exact Sciences Corporation | $148.67 | 2024-2025 | Cologuard Collection Kit |
| Genzyme Corporation | $123.14 | 2023-2025 | |
| Verona Pharma, INC. | $104.36 | 2025 | Ohtuvayre |
| Amgen INC. | $98.13 | 2024-2025 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $67.97 | 2023-2024 | Glassia, Aralast |
| Mallinckrodt Hospital Products INC. | $53.21 | 2025 | Acthar |
| Lilly USA, LLC | $45.22 | 2023 | Mounjaro |
| Viatris Specialty LLC | $44.84 | 2025 | Yupelri |
| Philips North America LLC | $41.33 | 2024-2025 | Mcot, (Ak6) Vest Therapy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $28.82 | 2025 | Dupixent |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.04 | 2020 | |
| Baxter Healthcare | $25.84 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Electromed, INC. | $24.70 | 2025 | Smartvest |
| Medicomp INC | $24.55 | 2025 | Telepatch Cardiac Monitor |
| Insmed, INC. | $21.23 | 2025 | Arikayce |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sami Pervaiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.